13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuropharmacology and Novel Drug Development
The field of neuropharmacology and novel drug development delves into the biochemical pathways and molecular targets underlying neurological function and dysfunction. This research area is pivotal in driving the creation of innovative drugs, ranging from neuroprotective agents to neuromodulators. Advanced methodologies, such as CRISPR-based genome editing and nanotechnology, are transforming the delivery and effectiveness of neurotherapeutics. Researchers are also focusing on strategies to overcome the challenges of the blood-brain barrier, ensuring enhanced drug delivery to the central nervous system. With a strong focus on addressing unmet clinical needs, neuropharmacology is expanding the frontiers of science, paving the way for groundbreaking solutions to neurological and psychiatric disorders.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)